Submitted by Anonymous (not verified) on 19 September 2024 - 13:30
Opinion/decision on a Paediatric investigation plan (PIP): Cystadrops, Cysteamine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Ophthalmology, PIP number: P/0019/2022
Source: